1 |
Afara, I. O., Prasadam, I., Crawford, R., Xiao, Y. and Oloyede, A. (2013) Near infrared (NIR) absorption spectra correlates with subchondral bone micro-CT parameters in osteoarthritic rat models. Bone 53, 350-357.
DOI
|
2 |
Bevaart, L., Vervoordeldonk, M. J. and Tak, P. P. (2010) Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum. 62, 2192-2205.
DOI
|
3 |
Brand, D. D., Latham, K. A. and Rosloniec, E. F. (2007) Collagen-induced arthritis. Nat. Protoc. 2, 1269-1275.
DOI
|
4 |
Carvalheiro, H., da Silva, J. A. and Souto-Carneiro, M. M. (2013) Potential roles for CD8(+) T cells in rheumatoid arthritis. Autoimmun. Rev. 12, 401-409.
DOI
|
5 |
Conway, J. R., Carragher, N. O. and Timpson, P. (2014) Developments in preclinical cancer imaging: innovating the discovery of therapeutics. Nat. Rev. Cancer 14, 314-328.
DOI
|
6 |
Gerwin, N., Bendele, A. M., Glasson, S. and Carlson, C. S. (2010) The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage 18 Suppl 3, S24-34.
|
7 |
Ishikawa, T., Nishigaki, F., Miyata, S., Hirayama, Y., Minoura, K., Imanishi, J., Neya, M., Mizutani, T., Imamura, Y., Naritomi, Y., Murai, H., Ohkubo, Y., Kagayama, A. and Mutoh, S. (2005) Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. Br. J. Pharmacol. 144, 133-143.
|
8 |
Koba, W., Jelicks, L. A. and Fine, E. J. (2013) MicroPET/SPECT/CT imaging of small animal models of disease. Am. J. Pathol. 182, 319-324.
DOI
|
9 |
Maruotti, N., Cantatore, F. P., Crivellato, E., Vacca, A. and Ribatti, D. (2007) Macrophages in rheumatoid arthritis. Histol. Histopathol. 22, 581-586.
|
10 |
Mello, S. B., Barros, D. M., Silva, A. S., Laurindo, I. M. and Novaes, G. S. (2000) Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. Rheumatology (Oxford) 39, 533-536.
DOI
|
11 |
Myers, L. K., Rosloniec, E. F., Cremer, M. A. and Kang, A. H. (1997) Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61, 1861-1878.
DOI
|
12 |
Nagase, H. and Woessner, J. F., Jr. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
DOI
|
13 |
Otero, M. and Goldring, M. B. (2007) Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res. Ther. 9, 220.
DOI
|
14 |
Ryu, J. H., Lee, A., Chu, J. U., Koo, H., Ko, C. Y., Kim, H. S., Yoon, S. Y., Kim, B. S., Choi, K., Kwon, I. C., Kim, K. and Youn, I. (2011) Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe. Arthritis Rheum. 63, 3824-3832.
DOI
|
15 |
Perkins, D. J., St Clair, E. W., Misukonis, M. A. and Weinberg, J. B. (1998) Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2). Arthritis Rheum. 41, 2205-2210.
DOI
|
16 |
Peterson, J. D., Labranche, T. P., Vasquez, K. O., Kossodo, S., Melton, M., Rader, R., Listello, J. T., Abrams, M. A. and Misko, T. P. (2010) Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis. Arthritis Res. Ther. 12, R105.
DOI
|
17 |
Ritsma, L., Vrisekoop, N. and van Rheenen, J. (2013) In vivo imaging and histochemistry are combined in the cryosection labelling and intravital microscopy technique. Nat. Commun. 4, 2366.
|
18 |
Schambach, S. J., Bag, S., Schilling, L., Groden, C. and Brockmann, M. A. (2010) Application of micro-CT in small animal imaging. Methods 50, 2-13.
DOI
|
19 |
Scott, D. L. (2012) Biologics-based therapy for the treatment of rheumatoid arthritis. Clin. Pharmacol. Ther. 91, 30-43.
DOI
|
20 |
Scott, D. L., Wolfe, F. and Huizinga, T. W. (2010) Rheumatoid arthritis. Lancet 376, 1094-1108.
DOI
|
21 |
Weinblatt, M. E., Weissman, B. N., Holdsworth, D. E., Fraser, P. A., Maier, A. L., Falchuk, K. R. and Coblyn, J. S. (1992) Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum. 35, 129-137.
DOI
|
22 |
Segawa, Y., Yamaura, M., Aota, S., Omata, T., Tuzuike, N., Itokazu, Y., Oka, H., Tamaki, H. and Nakamura, T. (1997) Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats. Bone 20, 457-464.
DOI
|
23 |
Takaishi, H., Kimura, T., Dalal, S., Okada, Y. and D'Armiento, J. (2008) Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr. Pharm. Biotechnol. 9, 47-54.
DOI
|
24 |
Weinblatt, M. E., Kaplan, H., Germain, B. F., Merriman, R. C., Solomon, S. D., Wall, B., Anderson, L., Block, S., Small, R., Wolfe, F. and et al. (1991) Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. J. Rheumatol. 18, 334-338.
|